期刊文献+

类风湿关节炎合并间质性肺病及血清表面活性蛋白研究进展 被引量:1

Research advance on interstitial lung disease in patient with rheumatoid arthritis and serum surfactant proteins
原文传递
导出
摘要 类风湿关节炎合并间质性肺病发病率、病死率高,早期易误诊、漏诊,尤其后期出现肺间质纤维化,临床治疗很困难。近年来,血清表面活性蛋白在间质性肺病研究较多。本文基于对类风湿关节炎合并间质性肺病的诊断和治疗进展方面的现代认识及血清表面活性蛋白在间质性肺病的研究进展进行综述,为该疾病早期诊断和治疗效果观察提供新的方法和手段。 The interstitial lung disease can usually be discovered in rheumatoid arthritis,and it has high incidence rate and case fatality. It can be misdiagnosis and missed diagnosis in early period, and appearance pulmonary interstitial fibrosis in end,which is very difficult to treat in clinic. Recent years, there are more research of serum surfactant protein in interstitial lung disease. This articles will review the diagnosis and treatment progress of interstitial lung disease complicated by rheumatoid arthritis, and research advance of serum surfactant proteins on interstitial lung disease, so that provide new approach of early diagnosis and therapeutic efficacy observation of this disease.
出处 《国际呼吸杂志》 2012年第2期143-146,共4页 International Journal of Respiration
基金 山西省太原市科技计划专项资助项目(100341)
关键词 类风湿关节炎 间质性肺病 表面活性蛋白 诊断 治疗 Rheumatoid arthritis Interstitial lung disease Surfactant proteins Diagnosis Therapeutics
  • 相关文献

参考文献22

二级参考文献97

共引文献105

同被引文献9

  • 1Villeneuve E, Nam J, Emery P. 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Rev Bras Reumatol, 2010, 50: 481-483.
  • 2American Thoracic Society. Idiopathic pulmonary fibrosis: diag- nosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med, 2000, 161 (2 Pt 1): 646- 664.
  • 3Takahashi H, Kumki Y, Tanaka H, et al. Serum levels of sur- factant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med, 2000, 162: 258-263.
  • 4Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Grit Care Med, 2000, 162(3 Pt 1): 1109-1114.
  • 5Ihn H, Asano Y, Kubo M, et al. Clinical significance of serum suffactant protein D (SP-D) in patients with polymyositis/der- matomyositis: correlation with interstitial lung disease. Rheuma- tology (Oxford), 2002, 41: 1268-1272.
  • 6Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfaetant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax, 2003, 58: 52-57.
  • 7Kum6novics G, Minier T, Radics J, et al. Comprehensive in- vestigation of novel serum markers of pulmonary fibrosis associ- ated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol, 2008, 26: 414-420.
  • 8李昕,巩路.血清表面活性蛋白与系统性红斑狼疮合并间质性肺病的相关性研究[J].中华风湿病学杂志,2009,13(5):320-323. 被引量:4
  • 9宋庆珍,高惠英,罗静,李小峰,茹晋丽,张莉芸,温鸿雁,甄俊平.类风湿关节炎合并间质性肺病患者血清表面活性蛋白A和D水平及临床意义[J].中华风湿病学杂志,2012,16(7):463-467. 被引量:9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部